| DNA sensing by the cGAS–STING pathway in health and disease M Motwani, S Pesiridis, KA Fitzgerald Nature Reviews Genetics 20 (11), 657-674, 2019 | 998 | 2019 |
| Design of amidobenzimidazole STING receptor agonists with systemic activity JM Ramanjulu, GS Pesiridis, J Yang, N Concha, R Singhaus, SY Zhang, ... Nature 564 (7736), 439-443, 2018 | 590 | 2018 |
| The methylosome, a 20S complex containing JBP1 and pICln, produces dimethylarginine-modified Sm proteins WJ Friesen, S Paushkin, A Wyce, S Massenet, GS Pesiridis, G Van Duyne, ... Molecular and cellular biology 21 (24), 8289-8300, 2001 | 505 | 2001 |
| Succination inactivates gasdermin D and blocks pyroptosis F Humphries, L Shmuel-Galia, N Ketelut-Carneiro, S Li, B Wang, ... Science 369 (6511), 1633-1637, 2020 | 408 | 2020 |
| Mutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis GS Pesiridis, VMY Lee, JQ Trojanowski Human molecular genetics 18 (R2), R156-R162, 2009 | 378 | 2009 |
| A “two-hit” hypothesis for inclusion formation by carboxyl-terminal fragments of TDP-43 protein linked to RNA depletion and impaired microtubule-dependent transport GS Pesiridis, K Tripathy, S Tanik, JQ Trojanowski, VMY Lee Journal of Biological Chemistry 286 (21), 18845-18855, 2011 | 135 | 2011 |
| A diamidobenzimidazole STING agonist protects against SARS-CoV-2 infection F Humphries, L Shmuel-Galia, Z Jiang, R Wilson, P Landis, SL Ng, ... Science Immunology 6 (59), eabi9002, 2021 | 111 | 2021 |
| Role of pICLn in methylation of Sm proteins by PRMT5 GS Pesiridis, E Diamond, GD Van Duyne Journal of biological chemistry 284 (32), 21347-21359, 2009 | 102 | 2009 |
| Discovery of GSK8612, a highly selective and potent TBK1 inhibitor DW Thomson, D Poeckel, N Zinn, C Rau, K Strohmer, AJ Wagner, ... ACS medicinal chemistry letters 10 (5), 780-785, 2019 | 63 | 2019 |
| Human rhinovirus promotes STING trafficking to replication organelles to promote viral replication M Triantafilou, J Ramanjulu, LM Booty, G Jimenez-Duran, H Keles, ... Nature Communications 13 (1), 1406, 2022 | 19 | 2022 |
| Preclinical characterization of GSK532, a novel STING agonist with potent anti-tumor activity J Yang, M Adam, J Clemens, K Creech, J Schneck, K Pasikanti, JL Tran, ... Cancer Research 78 (13_Supplement), 5554-5554, 2018 | 14 | 2018 |
| Targeting STING oligomerization with small-molecule inhibitors F Humphries, L Shmuel-Galia, Z Jiang, JY Zhou, L Barasa, S Mondal, ... Proceedings of the National Academy of Sciences 120 (33), e2305420120, 2023 | 13 | 2023 |
| Author correction: design of amidobenzimidazole STING receptor agonists with systemic activity JM Ramanjulu, GS Pesiridis, J Yang, N Concha, R Singhaus, SY Zhang, ... Nature 570 (7761), E53-E53, 2019 | 6 | 2019 |
| Modulators of stimulator of interferon genes (sting) DT Fosbenner, TL Graybill, J Kang, BW King, LAN Yunfeng, LK Leister, ... US Patent 11,377,440, 2022 | 5 | 2022 |
| Characterization of the Staphylococcus aureus Sortase Transpeptidase: A Novel Target for the Development of Chemotherapeutics Against Gram-Positive Bacteria R Kruger, S Pesiridis, DG McCafferty Peptides: The Wave of the Future: Proceedings of the Second International …, 2001 | 2 | 2001 |
| Methods for Administering STING Agonists GS Pesiridis, T Jean-Luc, Y Jingsong, JM Ramanjulu US Patent App. 16/753,365, 2020 | 1 | 2020 |
| Design of amidobenzimidazole STING receptor agonists with systemic activity (vol 564, pg 439, 2018) JM Ramanjulu, GS Pesiridis, JS Yang, N Concha, R Singhaus, SY Zhang, ... Nature 570 (7761), E53-E53, 2019 | | 2019 |
| Function of pICln in regulating PRMT5 activity through the combined interaction of the pICln-SmD3 complex GS Pesiridis University of Pennsylvania, 2006 | | 2006 |
| Volume 18 Review Issue 2 15 October 2009 GS Pesiridis, VMY Lee, JQ Trojanowski | | |
